Skip to main content
Year archive

PCI Biotech Holding — 2021 filings

All 50 regulatory filings released by PCI Biotech Holding (PCIB) in 2021, sourced directly from the official regulator.

50 Filings
2021 Period
2021 filings (50)
Filing Released Lang
PCI Biotech to present at DNB Nordic Healthcare Conference 2021
Regulatory Filings
2021-12-14 English
PCI Biotech: Independent Data Monitoring Committee recommends continuation of two treatments in the RELEASE trial
Legal Proceedings Report
2021-12-13 English
PCI Biotech: Update on regulatory interactions for the RELEASE trial
Regulatory Filings
2021-12-07 English
PCI Biotech and Immunicum Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments
Regulatory Filings
2021-11-30 English
PCI Biotech to present at ABGSC Nordic Rare Disease Seminar
Report Publication Announcement
2021-11-29 English
PCI Biotech Q3 2021 interim results
Investor Presentation
2021-11-17 English
PCI Biotech Q3 2021 interim results
Interim / Quarterly Report Q3 2021
2021-11-17 English
PCI Biotech Q3 2021 interim results
Report Publication Announcement
2021-11-17 English
PCI Biotech: Invitation to Q3 2021 result presentation
Report Publication Announcement
2021-11-09 English
PCI Biotech to present at the 9th International mRNA Health Conference
Regulatory Filings
2021-11-09 English
PCI Biotech to present at the 9th International mRNA Health Conference
Regulatory Filings
2021-11-09 English
PCI Biotech: Presentation of fimaChem for bile duct cancer at IPA masterclass series
Regulatory Filings
2021-11-08 English
PCI Biotech: Presentation of fimaChem for bile duct cancer at IPA masterclass series
Regulatory Filings
2021-11-08 English
PCI Biotech: Employee share option scheme
Director's Dealing
2021-09-06 English
PCI Biotech: Employee share option scheme
Director's Dealing
2021-09-06 English
Financial calendar
Report Publication Announcement
2021-08-31 English
PCI Biotech first half-year 2021 interim results
Investor Presentation
2021-08-31 English
PCI Biotech first half-year 2021 interim results
Interim / Quarterly Report H1 2021
2021-08-31 English
PCI Biotech first half-year 2021 interim results
Earnings Release H1 2021
2021-08-31 English
PCI Biotech: Invitation to first half-year 2021 result presentation
Report Publication Announcement
2021-08-23 English
Financial calendar
Report Publication Announcement
2021-06-25 English
PCI Biotech: US patent for the vaccine technology (fimaVacc) in combination with checkpoint inhibitors
Regulatory Filings
2021-05-31 English
PCI Biotech receives Orphan Drug Designation in South Korea for fimaporfin in the treatment of bile duct cancer
Legal Proceedings Report
2021-05-28 English
PCI Biotech Minutes from Annual General Meeting 2021
AGM Information
2021-05-28 English
PCI Biotech Minutes from Annual General Meeting 2021
AGM Information
2021-05-28 English
Disclosure of voting rights for Chairman of the Board
Declaration of Voting Results & Voting Rights Announcements
2021-05-27 English
PCI Biotech: Notice of Annual General Meeting 2021
Annual Report FY 2020
2021-05-07 English
PCI Biotech: Notice of Annual General Meeting 2021
Remuneration Information
2021-05-07 English
PCI Biotech: Notice of Annual General Meeting 2021
Governance Information
2021-05-07 English
PCI Biotech: Notice of Annual General Meeting 2021
AGM Information
2021-05-07 English
PCI Biotech: Notice of Annual General Meeting 2021
AGM Information
2021-05-07 English
PCI Biotech: Notice of Annual General Meeting 2021
AGM Information
2021-05-07 English
PCI Biotech: Notice of Annual General Meeting 2021
AGM Information
2021-05-07 English
PCI Biotech: Notice of Annual General Meeting 2021
AGM Information
2021-05-07 English
PCI Biotech first quarter 2021 interim results
Investor Presentation
2021-05-07 English
PCI Biotech first quarter 2021 interim results
Interim / Quarterly Report Q1 2021
2021-05-07 English
PCI Biotech first quarter 2021 interim results
Report Publication Announcement Q1 2021
2021-05-07 English
OliX Pharmaceuticals and PCI Biotech announce a collaboration to combine OliX asiRNA and PCI Biotech fimaNAc technologies
Regulatory Filings
2021-05-05 English
PCI Biotech: First US patient enrolled in the fimaChem pivotal RELEASE study
Legal Proceedings Report
2021-04-30 English
PCI Biotech: Invitation to first quarter 2021 results presentation
Report Publication Announcement
2021-04-30 English
PCI Biotech Holding ASA publishes the Annual Report 2020
Annual Report FY 2020
2021-04-21 English
PCI Biotech Holding ASA publishes the Annual Report 2020
Report Publication Announcement
2021-04-21 English
PCI Biotech to present at European Biotech Investor Days 2021
Regulatory Filings
2021-04-06 English
PCI Biotech fourth quarter and preliminary full year 2020 results
Investor Presentation
2021-02-24 English
PCI Biotech fourth quarter and preliminary full year 2020 results
Earnings Release Q4 2020
2021-02-24 English
PCI Biotech fourth quarter and preliminary full year 2020 results
Earnings Release Q4 2020
2021-02-24 English
PCI Biotech: Invitation to fourth quarter 2020 results presentation
Report Publication Announcement
2021-02-18 English
PCI Biotech - release of the RNA Therapeutics Virtual Conference presentation
Investor Presentation
2021-02-10 English
PCI Biotech - release of the RNA Therapeutics Virtual Conference presentation
Report Publication Announcement
2021-02-10 English
PCI Biotech to present at RNA Therapeutics Virtual Conference
Regulatory Filings
2021-01-22 English